(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane

C157H341FN30O8S — CID 158453204

IUPAC(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane
SMILESCC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)N1CCC(N)CC1.CC(C)(C)N1CCN(CCO)CC1.CC(C)(C)N1CCN(S(C)(=O)=O)CC1.CC(C)(C)N1CC[C@@H](N)C1.CC(C)N1CC(N)C1.CC(C)N1CCCOCC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CC[C@@H](N(C)C)[C@@H](F)C1.CC(C)N1C[C@@H](C)N[C@@H](C)C1.CC(C)N1C[C@@H](C)O[C@@H](C)C1.CCN1CCN(C(C)(C)C)CC1.CN(C)[C@H]1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)CC1.COC1CCN(C(C)(C)C)CC1.COC1CN(C(C)C)C1
InChIInChI=1S/2C11H24N2.C10H21FN2.C10H20N2O.C10H22N2O.3C10H22N2.C10H21NO.C9H20N2O2S.2C9H20N2.C9H19NO.C8H18N2.C8H17NO.C7H15NO.C6H14N2/c2*1-10(2)12-6-8-13(9-7-12)11(3,4)5;1-8(2)13-6-5-10(12(3)4)9(11)7-13;1-9(13)11-5-7-12(8-6-11)10(2,3)4;1-10(2,3)12-6-4-11(5-7-12)8-9-13;1-10(2,3)12-7-6-9(8-12)11(4)5;1-10(2,3)12-7-5-9(11-4)6-8-12;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)11-7-5-9(12-4)6-8-11;1-9(2,3)10-5-7-11(8-6-10)14(4,12)13;1-7(2)11-5-8(3)10-9(4)6-11;1-9(2,3)11-6-4-8(10)5-7-11;1-7(2)10-5-8(3)11-9(4)6-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2)9-4-3-6-10-7-5-9;1-6(2)8-4-7(5-8)9-3;1-5(2)8-3-6(7)4-8/h2*10H,6-9H2,1-5H3;8-10H,5-7H2,1-4H3;5-8H2,1-4H3;13H,4-9H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;7-10H,5-6H2,1-4H3;8H,4-7,10H2,1-3H3;7-9H,5-6H2,1-4H3;7H,4-6,9H2,1-3H3;8H,3-7H2,1-2H3;6-7H,4-5H2,1-3H3;5-6H,3-4,7H2,1-2H3/t;;9-,10+;;;9-;;;;;8-,9+;;8-,9+;7-;;;/m..0..0.......1.../s1
InChIKeyHEGFRCHCGHQCTO-BGWALMOFSA-N
MW2828.72 g/mol
LogP19.39
Rot. Bonds17

About (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane

(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane (PubChem CID 158453204) has the molecular formula C157H341FN30O8S and a molecular weight of 2828.72 g/mol. Its IUPAC name is (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane.

Molecular Properties

Compound Name(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane
PubChem CID158453204
Molecular FormulaC157H341FN30O8S
Molecular Weight2828.72 g/mol
Exact Mass2826.69
IUPAC Name(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane
SMILESCC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)N1CCC(N)CC1.CC(C)(C)N1CCN(CCO)CC1.CC(C)(C)N1CCN(S(C)(=O)=O)CC1.CC(C)(C)N1CC[C@@H](N)C1.CC(C)N1CC(N)C1.CC(C)N1CCCOCC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CC[C@@H](N(C)C)[C@@H](F)C1.CC(C)N1C[C@@H](C)N[C@@H](C)C1.CC(C)N1C[C@@H](C)O[C@@H](C)C1.CCN1CCN(C(C)(C)C)CC1.CN(C)[C@H]1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)CC1.COC1CCN(C(C)(C)C)CC1.COC1CN(C(C)C)C1
InChIInChI=1S/2C11H24N2.C10H21FN2.C10H20N2O.C10H22N2O.3C10H22N2.C10H21NO.C9H20N2O2S.2C9H20N2.C9H19NO.C8H18N2.C8H17NO.C7H15NO.C6H14N2/c2*1-10(2)12-6-8-13(9-7-12)11(3,4)5;1-8(2)13-6-5-10(12(3)4)9(11)7-13;1-9(13)11-5-7-12(8-6-11)10(2,3)4;1-10(2,3)12-6-4-11(5-7-12)8-9-13;1-10(2,3)12-7-6-9(8-12)11(4)5;1-10(2,3)12-7-5-9(11-4)6-8-12;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)11-7-5-9(12-4)6-8-11;1-9(2,3)10-5-7-11(8-6-10)14(4,12)13;1-7(2)11-5-8(3)10-9(4)6-11;1-9(2,3)11-6-4-8(10)5-7-11;1-7(2)10-5-8(3)11-9(4)6-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2)9-4-3-6-10-7-5-9;1-6(2)8-4-7(5-8)9-3;1-5(2)8-3-6(7)4-8/h2*10H,6-9H2,1-5H3;8-10H,5-7H2,1-4H3;5-8H2,1-4H3;13H,4-9H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;7-10H,5-6H2,1-4H3;8H,4-7,10H2,1-3H3;7-9H,5-6H2,1-4H3;7H,4-6,9H2,1-3H3;8H,3-7H2,1-2H3;6-7H,4-5H2,1-3H3;5-6H,3-4,7H2,1-2H3/t;;9-,10+;;;9-;;;;;8-,9+;;8-,9+;7-;;;/m..0..0.......1.../s1
InChIKeyHEGFRCHCGHQCTO-BGWALMOFSA-N
XLogP19.39
TPSA291.48 Ų
H-Bond Donors6
H-Bond Acceptors36
Rotatable Bonds17
Heavy Atoms197
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002828.72
LogP ≤ 519.39
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1036

Analyze (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane?
The IUPAC name of (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane (CID 158453204) is (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane.
What is the SMILES notation for (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane?
The canonical SMILES for (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane is CC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)N1CCC(N)CC1.CC(C)(C)N1CCN(CCO)CC1.CC(C)(C)N1CCN(S(C)(=O)=O)CC1.CC(C)(C)N1CC[C@@H](N)C1.CC(C)N1CC(N)C1.CC(C)N1CCCOCC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CCN(C(C)(C)C)CC1.CC(C)N1CC[C@@H](N(C)C)[C@@H](F)C1.CC(C)N1C[C@@H](C)N[C@@H](C)C1.CC(C)N1C[C@@H](C)O[C@@H](C)C1.CCN1CCN(C(C)(C)C)CC1.CN(C)[C@H]1CCN(C(C)(C)C)C1.CNC1CCN(C(C)(C)C)CC1.COC1CCN(C(C)(C)C)CC1.COC1CN(C(C)C)C1.
What is the InChIKey of (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane?
The InChIKey is HEGFRCHCGHQCTO-BGWALMOFSA-N. The full InChI is InChI=1S/2C11H24N2.C10H21FN2.C10H20N2O.C10H22N2O.3C10H22N2.C10H21NO.C9H20N2O2S.2C9H20N2.C9H19NO.C8H18N2.C8H17NO.C7H15NO.C6H14N2/c2*1-10(2)12-6-8-13(9-7-12)11(3,4)5;1-8(2)13-6-5-10(12(3)4)9(11)7-13;1-9(13)11-5-7-12(8-6-11)10(2,3)4;1-10(2,3)12-6-4-11(5-7-12)8-9-13;1-10(2,3)12-7-6-9(8-12)11(4)5;1-10(2,3)12-7-5-9(11-4)6-8-12;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)11-7-5-9(12-4)6-8-11;1-9(2,3)10-5-7-11(8-6-10)14(4,12)13;1-7(2)11-5-8(3)10-9(4)6-11;1-9(2,3)11-6-4-8(10)5-7-11;1-7(2)10-5-8(3)11-9(4)6-10;1-8(2,3)10-5-4-7(9)6-10;1-8(2)9-4-3-6-10-7-5-9;1-6(2)8-4-7(5-8)9-3;1-5(2)8-3-6(7)4-8/h2*10H,6-9H2,1-5H3;8-10H,5-7H2,1-4H3;5-8H2,1-4H3;13H,4-9H2,1-3H3;9H,6-8H2,1-5H3;9,11H,5-8H2,1-4H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;7-10H,5-6H2,1-4H3;8H,4-7,10H2,1-3H3;7-9H,5-6H2,1-4H3;7H,4-6,9H2,1-3H3;8H,3-7H2,1-2H3;6-7H,4-5H2,1-3H3;5-6H,3-4,7H2,1-2H3/t;;9-,10+;;;9-;;;;;8-,9+;;8-,9+;7-;;;/m..0..0.......1.../s1.
What are the key properties of (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane?
(3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane has a molecular weight of 2828.72 g/mol, XLogP of 19.39, 17 rotatable bonds, 6 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-1-tert-butyl-N,N-dimethylpyrrolidin-3-amine;1-tert-butyl-4-ethylpiperazine;1-tert-butyl-4-methoxypiperidine;1-tert-butyl-N-methylpiperidin-4-amine;1-tert-butyl-4-methylsulfonylpiperazine;2-(4-tert-butylpiperazin-1-yl)ethanol;1-(4-tert-butylpiperazin-1-yl)ethanone;1-tert-butylpiperidin-4-amine;bis(1-tert-butyl-4-propan-2-ylpiperazine);(3R)-1-tert-butylpyrrolidin-3-amine;(2R,6S)-2,6-dimethyl-4-propan-2-ylmorpholine;(3S,5R)-3,5-dimethyl-1-propan-2-ylpiperazine;(3S,4R)-3-fluoro-N,N-dimethyl-1-propan-2-ylpiperidin-4-amine;3-methoxy-1-propan-2-ylazetidine;1-propan-2-ylazetidin-3-amine;4-propan-2-yl-1,4-oxazepane is sourced from PubChem (CID 158453204), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).